DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / B••••••• A•••• M••••••••• L••
B••••••• A•••• M••••••••• L••
Since 2006, BroadOak Capital Partners has helped life sciences businesses achieve their full potential through direct investment and investment banking services.
Classification
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 8 of 9 distinct vehicles are sworn Private Equity Funds; 8 reported gross assets on a filing in 2022 or later
- Size band
- Lower middle marketdefined by: proxy: $0.35bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
- Strategies
- PRIVATE CREDIT
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 8 of 9 distinct vehicles are sworn Private Equity Funds; 8 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
- Adviser type
- registered investment adviser
- Form ADV filings
- Dec 14, 2011 to Mar 27, 2024
- RAUM
- $371Mregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 7
- PE fund GAV, latest filing
- $355Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $371Mevery private fund type, latest filing
- 2024 PE fund GAV
- $355Msum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 89%
- Fund type mix
- filed 2024-03-27, latest gav Private Equity Fund $355M, Venture Capital Fund $16.1M, latest counts Private Equity Fund 7, Venture Capital Fund 1, lifetime distinct Private Equity Fund 8, Venture Capital Fund 1
- Employees
- 8
- Headquarters
- Bethesda, MD
- Office address
- 4800 MONTGOMERY LANE, SUITE 230, Bethesda, MD, 20814
- Business phone
- 301-358-2692
Stated criteria beside observed behaviour
100 observed deals
Stated by the firm
- Sectors
- life sciences
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- BroadOak advises and invests in life sciences tools, diagnostics, and services companies.
Observed from deals on record
- roles
- add on 4, unknown 89, platform 11
- period
- to 2025-02-04, from 2018-05-18, undated holdings 87, dated observations 34
- window
- last 2025-02-04, first 2018-05-18
- control
- control 11, unknown 93
- companies
- 100
- geography
- count 2, share 0.02, value CA, count 1, share 0.01, value NJ
- investments
- 104
- seller kinds
- corporate parent 1
- transactions
- 17
- cadence by year
- 2018 add ons 2, 2019 add ons 1, 2021 platforms 4, 2022 add ons 1, platforms 2, other deals 4, 2023 platforms 1, other deals 1, 2025 other deals 1
- platform add on
- add ons 4, platforms 11, add ons per platform 0.36
- sector known for
- 7
- disclosed value usd
- n 0
- sector distribution
- count 3, share 0.03, value industrial manufacturing, examples ORFLO Technologies, Particle Dynamics, Argonaut Manufacturing Services, count 3, share 0.03, value life sciences, examples PBS Biotech, Inc., Kemp Proteins, Interpace Pharma Solutions, count 1, share 0.01, value software, examples LabVoice
- holding period years
- n 0
- repeat counterparties
- role legal adviser, shared 3, entity id a7bef4a2-fcc7-4e49-8388-085b0713f833, role sell side adviser, shared 2, entity id 2f634389-5d70-4d00-b431-e1ab4a5344ee, role legal adviser, shared 2, entity id be057615-70ef-4cb4-98a0-422ccf6143e5, role mezzanine lender, shared 2, entity id 4f8af7ea-70cd-4d01-9497-2eaed4c63d6b, role lender, shared 2, entity id d7930ba2-f29e-4259-9274-f98ca05eae4f
- subsector distribution
- count 3, share 0.03, value miscellaneous manufacturing, examples ORFLO Technologies, Particle Dynamics, Argonaut Manufacturing Services, count 3, share 0.03, value life sciences, examples PBS Biotech, Inc., Kemp Proteins, Interpace Pharma Solutions, count 1, share 0.01, value software, examples LabVoice
100 companies on the graph (17 transactions); most in industrial manufacturing (3); 11 platforms and 4 add-ons; observed 2018 to 2025
Funds
8 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| B••••••• I••••• F•••• L••• ADV: Private Equity Fund | Credit fund | 2024 first reported on Form ADV | $62.7M as of Mar 27, 2024 | no Form D | Unknown | |
| B••••••• F••• V• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $137M as of Mar 27, 2024 | no Form D | Unknown | |
| B••••••• F••• I• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $78.9M as of Mar 27, 2024 | no Form D | Active deployment | |
| B••••••• C•••••• 2•••• L•• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $35.7M as of Mar 27, 2024 | no Form D | Active deployment | |
| B••••••• F••• I••• L•• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $25.3M as of Mar 27, 2024 | no Form D | Unknown | |
| B••••••• C•••••• 2•••• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $8.1M as of Mar 27, 2024 | no Form D | Unknown | |
| B••••••• C•••••• 2•••• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $7.3M as of Mar 27, 2024 | no Form D | Unknown | |
| B••••••• F••• I• L•• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $6.8M as of Nov 30, 2022 | no Form D | Wound down |
Team
26 current, 0 former
Managing partner (3)
- L••• M••••• H•••• · Managing Member · since Jan 1, 2007 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- W•••••• F••••••• S••••• · Managing Member · since Jan 1, 2007 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- W•••••• S••••• · Co-Founder and Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
Partner (10)
- B••• S••••• · Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- B••• S••••• · Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- B••• S••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- D• K••• W••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- D••••• F••••••• · Managing Director · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- D••••• K••• W••••• · Owner/Partner · since Dec 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- L••• M••••• H•••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M••• M•••••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M•••••• C•••••• · Managing Director · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- T•• J•••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Vice president (6)
- A•••• F••••• · Vice President · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- C••••• A••••• · Vice President · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M•••••• B•••• · Vice President · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M•• W••• · Senior Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- P••• C••••• · Vice President of BD, Europe · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- R••••• Z•••• · Vice President · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Associate (1)
- H•••• D••••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Analyst (1)
- A••••• K••••• · Senior Analyst · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Operating partner (4)
- A•••• G•••••• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A••• P••••• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- A••••• D••• · Managing Director · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- T•••• C•••••• · Operating Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Platform (1)
- H•••• S•••• A•••••• · Chief Compliance Officer · start date unknown SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Portfolio
106 relationships, 11 platforms, 4 add-ons
Transactions
16 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Feb 4, 2025 | Type not stated | H•••••• I•••••••• | Sponsor (confirmed) | b•••••••.com |
| Apr 12, 2023 | Type not stated | i•••• l••• | Sponsor (confirmed) | b•••••••.com |
| Jan 9, 2023 | Platform acquisition | C•• L••••••••• | Sponsor (confirmed) | b•••••••.com |
| Oct 27, 2022 | Platform acquisition | O•••• T••••••••• | Sponsor (confirmed), Sponsor (confirmed) | b•••••••.com |
| Sep 28, 2022 | Growth investment | E•••••• R••••••• | Sponsor (confirmed) | b•••••••.com |
| Sep 1, 2022 | Add-on acquisition | I•••••••• P••••• S•••••••• | Sponsor (derived) | b•••••••.com |
| Jun 21, 2022 | Type not stated | K••• P••••••• | Sponsor (confirmed), Sponsor (confirmed) | b•••••••.com |
| Jun 7, 2022 | Type not stated | L••••••• | Sponsor (confirmed) | b•••••••.com |
| Mar 15, 2022 | Exit to a strategic buyer | R••••••• B•••••• | Seller (confirmed) | b•••••••.com |
| Sep 29, 2021 | Platform acquisition | P••••••• D••••••• | Sponsor (confirmed), Sponsor (confirmed) | b•••••••.com |
| Apr 21, 2021 | Platform acquisition | K••••••• | Sponsor (confirmed), Sponsor (confirmed) | b•••••••.com |
| Dec 20, 2020 | Add-on acquisition | D••••••••• B•• | Sponsor (derived), Seller (confirmed) | b•••••••.com |
| Dec 20, 2020 | Exit to a strategic buyer | D••••••••• B•• | Seller (confirmed) | b•••••••.com |
| Feb 19, 2019 | Add-on acquisition | P•••••••• G••• | Sponsor (confirmed) | b•••••••.com |
| Oct 18, 2018 | Add-on acquisition | C•••••• R•••• L••••••••• | Sponsor (confirmed) | b•••••••.com |
| May 18, 2018 | Add-on acquisition | K•• A••••• | Sponsor (confirmed) | b•••••••.com |
Placement agents, lenders, advisers and co-investors
10 relationships
Lenders (2)
- F•••• M•••••••• B••• 1 shared · one time · last Sep 29, 2021
- F••••••• C•••••• P••••••• 1 shared · one time · last Sep 29, 2021
Financial advisers (3)
- F•••••••• P••••••• 1 shared · one time · last Sep 29, 2021
- G••••••••• S••••••••• L•• 1 shared · one time · last Feb 4, 2025
- R•••••• J•••• L••• 1 shared · one time · last Feb 4, 2025
Legal advisers (4)
- P•••••••• W••••••• S••• P•••••• L•• 2 shared · recurring · last Feb 4, 2025
- B••• B•••• • S••• 1 shared · one time · last Feb 4, 2025
- T••• S••••••••• • H•••••••• L•• 1 shared · one time · last Sep 29, 2021
- R•••• • G••• L•• 1 shared · one time · last Feb 4, 2025
Co-investors (1)
- B••••••• 3 shared · strong · last Feb 19, 2019
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
58 most recent
- Aug 31, 2026B••••••• A•••• M••••••••• L••: Private Equity Funds on Form ADV 7 (2024 extract) -> 9 (roster 2026-09-01)
- Jun 25, 2026Agilent Completes Acquisition of Biocare Medical
- May 20, 2026InSphero AG Acquires PhenoVista B•••••••••, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities
- Oct 28, 2025B••••••• Capital Partners Adds More Than $200 Million of Permanent Capital to Supplement Investment Platform
- Aug 28, 2025Battery Ventures Completes Take-Private Transaction with Enzo Biochem
- Aug 7, 2025Scientific Industries completes the divestiture of its Genie division to Troemner, a subsidiary of Mettler-Toledo
- Jul 28, 2025P•••••••• Completes Investment Round to Expand Product Portfolio and Commercial Operations
- Jun 30, 2025P••••••• D••••••• acquires EuroAPI UK
- May 21, 2025Waters Acquires H••• L•••, Expanding Biological A••••••• Portfolio
- Feb 4, 2025R•••••• Founders Invests in H•••••• I••••••••
- Feb 4, 2025R•••••• Founders Invests in H•••••• I••••••••
- Jan 23, 2024ZoBio Sells to Oncodesign Services
- Dec 21, 2023P•••••••• Closes Major Fundraising Round
- Jul 11, 2023celares G••• Sells to B•••••••
- Apr 12, 2023I•••• L••• Investment from B••••••• BioTools Venture Fund
- Apr 12, 2023I•••• L••• Investment from B••••••• BioTools Venture Fund
- Jan 9, 2023B••••••• Invests in C•• L•••••••••
- Jan 9, 2023B••••••• Invests in C•• L•••••••••
- Jan 9, 2023Sanguine B••••••••• Partners with B•••••••
- Dec 14, 2022FujiFilm Invests in PhenoVista B•••••••••
- Nov 22, 2022BioCare Medical Acquires E••••• G•••••••
- Oct 27, 2022B••••••• Partners with United Biochannels to Acquire O•••• T•••••••••
- Oct 27, 2022B••••••• Partners with United Biochannels to Acquire O•••• T•••••••••
- Sep 30, 2022F••••••• B••••••••• hires Tom Turi, Ph.D. as CSO
- Sep 28, 2022B••••••• Invests in E•••••• R•••••••
- Sep 28, 2022B••••••• Invests in E•••••• R•••••••
- Sep 1, 2022F••••••• Acquires I••••••••'s P••••• Services Business
- Jul 11, 2022B••••••• Increases Investment in H••• L•••
- Jun 21, 2022B••••••• Invests in K••• P•••••••
- Jun 21, 2022B••••••• Invests in K••• P•••••••
- Jun 20, 2022BRT Sells to Medix Biochemica
- Jun 7, 2022B••••••• Announces Investment in L•••••••Platform investmentFactL•••••••Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- Jun 7, 2022B••••••• Announces Investment in L•••••••
- May 25, 2022B••••••• Carbosynth Acquires Aalto Bio Reagents
- May 12, 2022Biolog Announces New Leadership Team and Investment
- Mar 15, 2022R••••••• B•••••• Acquired by Cobepa
- Mar 15, 2022R••••••• B•••••• Acquired by Cobepa
- Jan 22, 2022MyChem Sells To Maravai L•••S•••••••
- Nov 20, 2021JMI Announces Sale to Element Materials Technology
- Oct 11, 2021Nanosyn Sells to Element Materials Technology
- Sep 29, 2021B••••••• Leads Acquisition of P••••••• D•••••••
- Sep 29, 2021B••••••• Leads Acquisition of P••••••• D•••••••
- Jun 29, 2021V••••• B••••••••• Acquired by C•••••• R•••• L•••••••••
- Apr 21, 2021K••••••• Receives $2M Investment From B••••••• Capital PartnersPlatform investmentFactK•••••••Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- Apr 21, 2021K••••••• Receives $2M Investment From B••••••• Capital Partners
- Mar 21, 2021B••••••• Leads Investment In G••••••••
- Dec 20, 2020D••••••••• B•• Acquired By C•••••• R•••• L•••••••••
- Dec 20, 2020D••••••••• B•• Acquired By C•••••• R•••• L•••••••••
- Apr 20, 2020Bryan Poltilove Joins B••••••• Capital Partners Team
- Nov 19, 2019InFuse Holdings Closes Series A Financing And Acquires H•••••• I••••••••
- Sep 19, 2019A•••• B••tech Acquired By Arcline Investment Management
- Apr 19, 2019A••••• B•• Sells To BioL••• S••••••••
- Feb 19, 2019R••••••• B•••••• Acquires P•••••••• G•••
- Oct 18, 2018D••• Instruments Sells To PerkinElmer
- Oct 18, 2018D••••••••• B•• Partners With C•••••• R•••• L•••••••••
- Sep 18, 2018L•••Span B••••••••• Sells To Thompson Street
- May 18, 2018A••••• B•• Acquires K•• A••••• From M••••••••
- Dec 14, 2011B••••••• A•••• M••••••••• L•• first filed Form ADV in the extract (IA)
Across the graphs
B••••••• A•••• M••••••••• L•• is the same institution as 3 records in Venture Capital, Independent Sponsors and RIA and Wealth.
Venture Capital1Independent Sponsors1RIA and Wealth1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…